A*STAR AND RIKEN CELEBRATE 10 YEARS OF RESEARCH COLLABORATION

Singapore's Agency for Science, Technology and Research and Japan's Riken have marked a 10-year milestone of research partnership.

Singapore—The Agency for Science, Technology and Research (A*STAR) and RIKEN, Japan's largest comprehensive research institute in the natural sciences, have marked a 10-year milestone of research partnership.

A*STAR and RIKEN inked their first MOU September 2005 to encourage more opportunities for scientific exchange between Singapore and Japan. The MOU has since been renewed three times. For a timeline of milestones, refer to Annex A (in the link below).

RIKEN established its first overseas international liaison office in 2006, attesting to its long-term commitment to the partnership with Singapore. The partnership has catalysed joint projects in fields ranging from the biomedical sciences to the physical sciences and engineering domains (in Annex B in the link below). This partnership has also offered opportunities to broaden scientific exchange through RIKEN’s prestigious summer programmes in brain science and immunology.

The most recent renewal of the MOU will further build on the existing partnership to include mutual areas of interest in material science. This will continue to encourage sharing of ideas, co-advancing scientific capabilities, broadening research networks, and developing research talent.

Collaborative projects between A*STAR and RIKEN

Biomaterials and hydrogels: Dr Loh Xian Jun from A*STAR’s Institute of Materials Research and Engineering (IMRE) and Prof Yoshihiro Ito from RIKEN have successfully pioneered a new method of cell detachment using a novel temperature-sensitive biomaterial. This method has many applications in basic research, allowing scientists to better study adult human stem cells more efficiently. Currently, the process requires complicated chemical synthesis techniques whereas the new approach uses a “Drop-and-Dry” coating method. This method allows non-chemists to prepare their own temperature responsive cell culture surface for non-enzymatic detachment. This method will simplify experiments and facilitate the understanding of the cell differentiation process..

Identification of novel immune cell subset: Dr Florent Ginhoux from A*STAR’s Singapore Immunology Network (SIgN) is collaborating with Dr Ichiro Taniuchi from the RIKEN Center for Integrative Medical Sciences, to characterize novel lymphoid populations in the epidermis. Tapping on IMS’s strength in generating gene-manipulated mice and on SIgN’s flow cytometry and bioinformatics analyses of small cell populations, the collaboration identified a novel lymphoid cell subset in the epidermis in mice and humans. This finding, which will soon be published in Nature Scientific Reports, has provided new insights into the skin’s immune system and will deepen our understanding of the physiological and pathological roles of these new cell types during immune responses at the interface between our body and the environment.
Mr Lim Chuan Poh, Chairman A*STAR, said: “I am pleased that A*STAR’s and RIKEN’s longstanding partnership has catalysed many opportunities for collaboration in R&D between Singapore and Japan. We will continue to build on the complementary research capabilities of both countries through joint projects and scientific exchange. I look forward to many more fruitful years of collaboration.”

Dr Hiroshi Matsumoto, President of RIKEN, said: “RIKEN’s collaborations with Singapore through A*STAR have been extremely meaningful to us. A major mission of science today is to ensure the continued survival of humanity, and this mission cannot be accomplished without international cooperation. I strongly hope that our partnership will continue to develop, leading to important research breakthroughs that will benefit all of humanity.”

For media queries and clarifications, please contact:

A*STAR:

Dave Lee

Senior Officer, Corporate Communications

Agency for Science, Technology and Research

Tel: +65 6419 6508

Email: [email protected]

Lisa Chong

Manager, Corporate Communications

Agency for Science, Technology and Research

Tel: +65 6419 6544

Email: [email protected]

RIKEN:

Jens Wilkinson

Global Communications Team

RIKEN

Tel: +81 48-462-1225

Email: [email protected]

________________________________________________________________

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society.

As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by contributing to societal benefits such as improving outcomes in healthcare, urban living, and sustainability.

We play a key role in nurturing and developing a diversity of talent and leaders in our Agency and Research Institutes, the wider research community and industry. A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities primarily located in Biopolis and Fusionopolis.

For more information on A*STAR, please visit www.a-star.edu.sg.

About RIKEN

RIKEN is Japan's largest research institute for basic and applied research. Over 2500 papers by RIKEN researchers are published every year in leading scientific and technology journals covering a broad spectrum of disciplines including physics, chemistry, biology, engineering, and medical science. RIKEN's research environment and strong emphasis on interdisciplinary collaboration and globalization has earned a worldwide reputation for scientific excellence.

Website: www.riken.jp/en/

Facebook: www.facebook.com/RIKEN.english

Twitter: @riken_en

Published: 05 Aug 2015

Contact details:

General inquiries

1 Fusionopolis Way, #20-10
Connexis North Tower
Singapore 138632

(65) 6826 6111
Country: 
Journal:
News topics: 
Content type: 
Websites: 
Reference: 

Cell